Table 5.
Reason | Reporting ratea (%) N = 768 |
---|---|
Concerns about vaccine efficacy | 77 (10.0) |
Concerns about vaccine safety | 278 (36.2) |
Perception that COVID-19 is not a dangerous disease | 24 (3.1) |
Not enough information about the vaccine | 575 (74.9) |
Perception of not being at risk for infection | 30 (3.9) |
Other reasonb | 35 (4.5) |
Percentages do not round up to 100 since more than one answers were acceptable.
In 19 cases, the HCP raised concerns about the rapid development and entry of COVID-19 vaccines in the market.